Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immunic Inc shares valued at $32,076 were purchased by Whaley Glenn on Jun 03 ’25. At $0.71 per share, Whaley Glenn acquired 45,000 shares. The insider’s holdings grew to 95,510 shares worth approximately $73542.7 following the completion of this transaction.
Also, Rudick Richard Alan purchased 143,075 shares, netting a total of over 100,024 in proceeds. Following the buying of shares at $0.70 each, the insider now holds 230,375 shares.
Before that, Rudick Richard Alan had added 87,300 shares to its account. In a trade valued at $100,369, the Director bought Immunic Inc shares for $1.15 each. Upon closing the transaction, the insider’s holdings increased to 87,300 shares, worth approximately $67221.0.
As published in their initiating research note from William Blair on March 25, 2025, Immunic Inc [IMUX] has been an Outperform. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late November. Earlier on August 27, 2024, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for IMUX stock.
Analyzing IMUX Stock Performance
During the last five days, there has been a drop of approximately -14.85%. Over the course of the year, Immunic Inc shares have dropped approximately -22.50%. Shares of the company reached a 52-week high of $1.3900 on 02/21/25 and a 52-week low of $0.5600 on 05/29/25.
Support And Resistance Levels for Immunic Inc (IMUX)
According to the 24-hour chart, there is a support level at 0.7415, which, if violated, would cause prices to drop to 0.7080. In the upper region, resistance lies at 0.7920. The next price resistance is at 0.8090. RSI (Relative Strength Index) is 38.95 on the 14-day chart, showing neutral technical sentiment.
